Australia markets closed

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2500-0.1000 (-7.41%)
At close: 1:00PM EST
1.2700 +0.02 (+1.60%)
After hours: 04:28PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 541.46M
Enterprise value 3-20.67M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)5.39
Price/book (mrq)0.68
Enterprise value/revenue 3-2.98
Enterprise value/EBITDA 70.24

Trading information

Stock price history

Beta (5Y monthly) 1.77
52-week change 3-78.23%
S&P500 52-week change 329.82%
52-week high 37.5500
52-week low 31.2400
50-day moving average 33.4180
200-day moving average 34.4564

Share statistics

Avg vol (3-month) 3570.91k
Avg vol (10-day) 31.58M
Shares outstanding 531.41M
Implied shares outstanding 6N/A
Float 822.25M
% held by insiders 14.35%
% held by institutions 160.08%
Shares short (14 Nov 2021) 4515.02k
Short ratio (14 Nov 2021) 40.76
Short % of float (14 Nov 2021) 41.65%
Short % of shares outstanding (14 Nov 2021) 41.64%
Shares short (prior month 14 Oct 2021) 4422.52k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 312 Feb 2017
Ex-dividend date 419 Aug 2015
Last split factor 21:15
Last split date 312 Feb 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021


Profit margin 0.00%
Operating margin (ttm)-1,247.25%

Management effectiveness

Return on assets (ttm)-56.76%
Return on equity (ttm)-111.78%

Income statement

Revenue (ttm)6.93M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)157.40%
Gross profit (ttm)-40.39M
Net income avi to common (ttm)-86.51M
Diluted EPS (ttm)-3.0550
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)64.53M
Total cash per share (mrq)2.05
Total debt (mrq)2.39M
Total debt/equity (mrq)3.94
Current ratio (mrq)4.29
Book value per share (mrq)1.93

Cash flow statement

Operating cash flow (ttm)-88.19M
Levered free cash flow (ttm)-56.27M